
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.07 | -2.61194029851 | 2.68 | 2.805 | 2.32 | 664327 | 2.57415625 | CS |
4 | -0.78 | -23.0088495575 | 3.39 | 3.54 | 2.32 | 545430 | 2.8141875 | CS |
12 | -0.87 | -25 | 3.48 | 4.24 | 2.32 | 893710 | 3.24429159 | CS |
26 | -12.74 | -82.996742671 | 15.35 | 16.31 | 2.32 | 1186352 | 6.33390084 | CS |
52 | -7.79 | -74.9038461538 | 10.4 | 19.05 | 2.32 | 2363231 | 12.29259079 | CS |
156 | -1.153 | -30.6404464523 | 3.763 | 19.05 | 2.05 | 1659745 | 10.33188017 | CS |
260 | -1.153 | -30.6404464523 | 3.763 | 19.05 | 2.05 | 1659745 | 10.33188017 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.